Rigel Pharmaceuticals (RIGL) Leases (2019 - 2025)
Rigel Pharmaceuticals (RIGL) has 7 years of Leases data on record, last reported at $920000.0 in Q4 2025.
- For Q4 2025, Leases rose 273.98% year-over-year to $920000.0; the TTM value through Dec 2025 reached $920000.0, up 273.98%, while the annual FY2025 figure was $920000.0, 273.98% up from the prior year.
- Leases reached $920000.0 in Q4 2025 per RIGL's latest filing, down from $1.0 million in the prior quarter.
- Across five years, Leases topped out at $15.9 million in Q1 2021 and bottomed at $246000.0 in Q4 2024.
- Average Leases over 5 years is $4.0 million, with a median of $1.2 million recorded in 2023.
- Peak YoY movement for Leases: tumbled 85.03% in 2023, then skyrocketed 273.98% in 2025.
- A 5-year view of Leases shows it stood at $9.7 million in 2021, then plummeted by 80.11% to $1.9 million in 2022, then crashed by 55.39% to $861000.0 in 2023, then plummeted by 71.43% to $246000.0 in 2024, then surged by 273.98% to $920000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $920000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.2 million in Q2 2025.